SHANNON HOULIHAN: Open Payments
NPI 1215561949 · TAUNTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 39 payments from 14 companies in 2025. Trend: 2023 $283 · 2024 $906 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $253 |
| Lilly USA, LLC | 7 | $176 |
| PFIZER INC. | 6 | $127 |
| Novo Nordisk Inc | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: MOUNJARO, FARXIGA, BREZTRI, ELIQUIS, AIRSUPRA, ZORYVE, JARDIANCE, PREVNAR 20.
Industry payments across MA — which companies pay providers there.
